All News

Bills mysteriously paid. Old friends reunited. These are some of the stories of compassion told by people touched by cancer.

The Defeat GBM Research Collaborative is an effort based around three broad ideas: five years, $10 million and a question.

Kendra Sweet, M.D., discussed the various factors that must be taken into account when prescribing first-line therapies to patients with CML, the novel studies that are paving the way for improved outcomes in patients, and the increasing likelihood for TKI discontinuation on the horizon.

Can a drug used to treat arthritis also be a way to treat polycythemia vera (PV), and save patients with the blood cancer money?

Lymphedema can cause problems when you run out of veins.

MPN treatment and diagnostic strategies have come a long way in recent years, but still have a ways to go.

During an interview with CURE, Desai, an assistant professor of medicine at Stanford Medicine, shared insight on his research in stem cells and why discovering which cells have the potential to form lung cancer is significant to the treatment paradigm.

Patients with neuroendocrine tumors have more treatment options than ever before.

When everyone around you expects an endless fight against cancer, hope and love and acceptance are powerful forces.

Finding clothing that fits is a constant challenge for those suffering from the side effects of lymphedema. One survivor shares her dilemma.

Future treatment of ovarian cancer will include more interaction between molecular pathology and clinical pathology where genetic information can lead to more accurate pathologic diagnosis.

If you want to take botanicals to help fight your cancer, be sure they have been studied.

Losing their hair is one more way that cancer makes patients feel they've lost control over their bodies. It's not just physical, it's personal. Here are some tips for what to say.

Positive clinical trial results are released at a critical moment in time.

Leaving nipples intact during mastectomy can cosmetically improve breast reconstruction results without raising the risk of cancer recurrence, a study has shown.

Does the fear of a recurrence of breast cancer haunt every cancer survivor? Are these feelings normal? How can we combat these feelings of fear?

These are just some of the things that have changed in my life since my mastectomy. Maybe they are things that I have chosen to change.

People respond to cancer in a number of ways, but blaming the patient should never be one of them.

Acalabrutinib was granted a priority review to a new drug application (NDA) to be used to treat patients with mantle cell lymphoma (MCL) who have had previous treatment, according to AstraZeneca, the manufacturer of the drug.

How I’m learning to survive cancer and aging at the same time

Screening cancer caregivers for symptoms of depression could alert them to steps to offset the worsening physical health which caregivers often experience.

Vyxeos (CPX-351) was granted FDA approval for two subtypes of acute myeloid leukemia.

Using mediation and proper breathing can assist with pain management.

Breast cancer survivor approaches the phone with dread with Mom in hospice with breast cancer.

Imbruvica (ibrutinib) was granted approval by the FDA for the treatment of previously treated chronic graft versus host disease (cGVHD).

One of CURE's followers on Facebook recounted this gem: "Do you think you got breast cancer because of sin?"

The process of picking out the perfect mastectomy bra and prostheses is often emotional but with time, the selection process becomes easier.

There are many questions associated with breast cancer testing and their accuracy. Do tumor markers give accurate understanding of what's happening in an person's body? Why do some doctors use the test and some do not? These are just a couple of the questions we need answered.

Idhifa (enasidenib) was granted approval by the Food and Drug Administration (FDA) today, for the treatment of patients who have relapsed or refractory IDH2-mutated acute myeloid leukemia (AML).

Fighting retroperitoneal sarcoma can be like fighting a rare and giant beast.